Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-13
2005-09-13
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S113000
Reexamination Certificate
active
06943174
ABSTRACT:
The present invention provides compounds of Formula (I) wherein Q1, Q2, Q3, Q4, Y1, Y2, and Z are as defined in the description, and pharmaceutically acceptable salts thereof, and C1-C8alkyl esters thereof, which are useful for the treatment of diseases responsive to the inhibition of the enzyme 15-lipoxygenase. Thus, the compounds of Formula (I) and their pharmaceuticalyl acceptable salts are useful for treating diseases with an inflammatory component, including atherosclerosis, diseases involving chemotaxis of monocytes, inflammation, stroke, coronary artery disease, asthma, arthritis, colorectal cancer, and psoriasis.
REFERENCES:
patent: 3985891 (1976-10-01), Kutter et al.
patent: 4582837 (1986-04-01), Hauel et al.
patent: 4603139 (1986-07-01), King
patent: 4696931 (1987-09-01), Hauel et al.
patent: 4758574 (1988-07-01), Robertson et al.
patent: 4904785 (1990-02-01), Robertson et al.
patent: 5141950 (1992-08-01), Nakane et al.
patent: 5589482 (1996-12-01), Thompson
patent: 5972980 (1999-10-01), Cornicelli et al.
patent: 6140317 (2000-10-01), Traxler et al.
patent: 6180636 (2001-01-01), Traxler et al.
patent: 6180643 (2001-01-01), Zablocki et al.
patent: 6440973 (2002-08-01), Zablocki et al.
patent: 2 305 339 (1974-08-01), None
patent: 23 61 757 (1975-06-01), None
patent: 32 24 512 (1984-01-01), None
patent: 4227791 (1993-02-01), None
patent: 0 079 083 (1983-05-01), None
patent: 09 093 593 (1983-11-01), None
patent: 0 419 210 (1991-03-01), None
patent: WO 97/12613 (1997-04-01), None
patent: WO 98/08847 (1998-03-01), None
patent: WO 98/43973 (1998-10-01), None
patent: WO 01/30778 (2001-05-01), None
Kuhn et al. Prostaglandins & Other Lipid Mediators. 2002, 68-69:263-90.
Kuhn H and Chan L. Current Opinion in Lipidology. 1997, 8(2):111-7.
Whitman et al. J. Med. Chem. 2002 45:2659-2661.
Robertson, David W., et al, “Structure-Activity Relationships of Arylimidazopyridine Cardiotonics: Discovery and Inotropic Activity of 2-[2-Methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine”, J. Med. Chem, 1985, vol. 28, pp 717-727; XP 000577047.
Ertepinar, H., et al, “A QSAR study of the biological activities of some benzimidazoles and imidazopyridines againstBacillus subtilis”, Eur J Med Chem, vol. 30, 1995; pp 171-175.
International Search Report for PCT/US01/15112.
Picard Joseph Armand
Roark William Howard
Sliskovic Drago Robert
Baude Eric J.
Huang Evelyn Mei
Purchase, Jr. Claude F.
Warner-Lambert & Company
LandOfFree
6,5-Fused bicyclic heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 6,5-Fused bicyclic heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,5-Fused bicyclic heterocycles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3410502